SCHEMBL29549786

SCHEMBL29549786

Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 1.00
RET P07949 5/20 1.00
FGFR1 P11362 5/20 1.00
FLT1 P17948 5/20 1.00
PDGFRB P09619 3/20 1.00
PDGFRA P16234 3/20 1.00
MAP4K4 O95819 6/20 0.64
MAP4K2 Q12851 6/20 0.64
CLK4 Q9HAZ1 6/20 0.64
PLK4 O00444 5/20 0.64
MARK3 P27448 5/20 0.64
AXL P30530 5/20 0.64
LIMK1 P53667 5/20 0.64
CSNK1G2 P78368 5/20 0.64
STK3 Q13188 5/20 0.64
CAMK2G Q13555 5/20 0.64
CAMK2D Q13557 5/20 0.64
MARK2 Q7KZI7 5/20 0.64
HIPK4 Q8NE63 5/20 0.64
SLK Q9H2G2 5/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034036 1.00 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL29550161 0.85 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL17034041 0.85 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL13861829 0.79 KDR (0.79) KDRRETFGFR1FLT1PDGFRB
SCHEMBL4486611 0.78 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL4721372 0.76 PLK4 (0.89) KDRRETFGFR1FLT1PDGFRB
SCHEMBL17034055 0.76 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL29549573 0.75 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL17034027 0.75 KDR (1.00) KDRRETFGFR1FLT1PDGFRB
SCHEMBL5478260 0.74 PLK4 (1.00) KDRRETFGFR1FLT1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3112351-B1 NAPHTHYLAMIDE COMPOUND, PREPARATION METHOD AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2022-03-30 EP disclosed